Article and Video CATEGORIES
Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
For information on Dr. Gupta see the following links -
GRACE is very excited to bring you more of our program on supportive care in cancer treatment.
Arjun Gupta, MD, one of the GRACE Fellows Ambassador Program Winners for 2019 is the host of this video series, Supportive Care in Cancer Treatment. In this video, Dr. Gupta's guest is Dr. Dawn Hershman, with Columbia University in New York. Their topic of discussion is Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia).
Aromatase inhibitors (ais) are commonly used as adjuvant treatment in postmenopausal women with hormone receptor–positive early breast cancer. Arthralgia is often defined as an aching or pain in the joints without swelling, and can include stiffness, joint pain, redness and the reduced ability to move your joints. This is not to be confused with arthritis -- which is more likely pain with swelling of the joints.
For comments or questions, join the conversation, visit https://cancergrace.org/forums/general-breast-cancer.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…